Luca Mologni

5.8k citations
91 papers · 3.4k indexed · h-index 32
Topics
Lung Cancer Treatments and Mutations (28 papers)Lymphoma Diagnosis and Treatment (14 papers)Chronic Myeloid Leukemia Treatments (13 papers)

In The Last Decade

Luca Mologni

86 papers receiving 3.3k citations

Peers

Luca Mologni
Comparison fields: 5 of 101
  • Molecular Biology 1.7k
  • Hematology 1.1k
  • Oncology 942
  • Genetics 784
  • Pulmonary and Respiratory Medicine 596
Replace Markus Warmuth with:
Markus Warmuth United States
William C. Shakespeare United States
Christopher A. Eide United States
Outi Kilpivaara Finland
Lori Hazlehurst United States
Claudia Scholl Germany
Paolo Neviani United States
Suzanne Trudel Canada
Isabelle Plo France
T G Lugo United States
Luca Mologni relative to Markus Warmuth United States Markus Warmuth's profile →
Citations per field
00.5×
Markus Warmuth · 1×
Citations per year

Countries citing papers authored by Luca Mologni

Since Specialization
Citations

This map shows the geographic impact of Luca Mologni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Mologni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Mologni more than expected).

Fields of papers citing papers by Luca Mologni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Mologni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Mologni. The network helps show where Luca Mologni may publish in the future.

Co-authorship network of co-authors of Luca Mologni

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Mologni. A scholar is included among the top collaborators of Luca Mologni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Mologni. Luca Mologni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 3
5 1
6 2
7 10
8 5
9 11
10 10
11 10
12 27
13 7
14 61
15 17
16 47
17 22
18 71
19 26
20 41

About Luca Mologni

Luca Mologni is a scholar working on Hematology, Genetics and Oncology, having authored 91 papers that have together received 3.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (28 papers), Lymphoma Diagnosis and Treatment (14 papers) and Chronic Myeloid Leukemia Treatments (13 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (784 citations) and Oncology (942 citations). Luca Mologni has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Carlo Gambacorti‐Passerini, Edoardo Marchesi, Philipp le Coutre, Monica Ceccon, Sara Redaelli, Iván Plaza-Menacho, Franca Formelli, Loredana Cleris, Elisa Sala and Gonçalo J. M. Cabrita. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026